Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunityRalf Gutzmer, Anika Koop, Friedegund Meier, et al.
Cancer Treatment Reviews|February 29, 2016
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapyThomas K Eigentler, Jessica C Hassel, Carola Berking, et al.
Plos One|May 7, 2025
Prognostic and predictive value of IDO expression in metastatic melanoma treated with IpilimumabDagmar von Bubnoff, Christina Schmitt, Simone M Goldinger, et al.
European Journal of Cancer Care|August 21, 2018
Fear of cancer progression in patients with stage IA malignant melanomaTobias Wagner, Matthias Augustin, Christine Blome, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2018
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersKatharina C Kähler, Thomas K Eigentler, Anja Gesierich, et al.
Melanoma Research|March 3, 2017
Interactions from complementary and alternative medicine in patients with melanomaCarmen Loquai, Irene Schmidtmann, Marlene Garzarolli, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016]M M Hoeper, C Apitz, E Grünig, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2015
Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal studyE Livingstone, C Krajewski, T K Eigentler, et al.
Pageof 11